lobbying_activities: 1582369

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1582369	e5022312-9ea8-42e2-9963-4bf0eb73e973	Q3	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2014	third_quarter	HCR	Worked with congressional offices on issues regarding the challenges of developing products for rare diseases. Met with Congress regarding "21st Century Cures," including company presentation. Met with Congress regarding DEA issues.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2014-10-07T15:50:39.857000-04:00